HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Painful withdrawal for makers of Vioxx: pulling of arthritis drug raises questions on marketing, safety risks.

AuthorsBrooke A Masters, Marc Kaufman
JournalThe Washington post (Washington Post) Pg. A1, A8 (Oct 18 2004) United States
PMID15586941 (Publication Type: Newspaper Article)
Chemical References
  • Lactones
Topics
  • Advertising
  • Arthritis (drug therapy)
  • Cardiovascular Diseases (chemically induced)
  • Drug Approval
  • Drug Industry
  • Humans
  • Lactones (adverse effects)
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: